3 completed, 1 recruiting, 1 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Recruiting 1, Terminated 1 |
Follow asimadoline: new trials by email Literature Review of asimadoline trials Research Report on asimadoline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS). Asimadoline - Vasomotor Symptoms | Phase 2 | Recruiting | Tioga Pharmaceuticals | 120 | 2025-08-13 | 2026-10-08 |
| Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis Asimadoline, Placebo - Pruritus, Atopic Dermatitis | Phase 2 | Completed | Tioga Pharmaceuticals | 249 | 2015-07-01 | 2017-12-13 |
| Asimadoline for the Treatment of Post-Operative Ileus Asimadoline, Placebo - Post-Operative Ileus | Phase 2 | Terminated | Tioga Pharmaceuticals | 35 | 2007-01-01 | 2012-01-06 |
| Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome Asimadoline, Placebo - Irritable Bowel Syndrome | Phase 2 | Completed | Tioga Pharmaceuticals | 596 | 2006-08-01 | 2011-10-18 |
| Effect of Asimadoline, a Member of a New Medication Class, on Acute Attacks of Pain in Irritable Bowel Syndrome asimadoline - Irritable Bowel Syndrome | Phase 2 | Completed | Mayo Clinic | 100 | 2005-01-01 | 2011-03-23 |
Irritable Bowel Syndrome (2) · Dermatitis, Atopic (1) · Hot Flashes (1) · Pruritus (1)
Tioga Pharmaceuticals (4) · Mayo Clinic (1)
United States (5)
Allen Mangel, MD, PhD (2) · Dawn McGuire, MD FAAN (1) · Sergey Sikora, VP of Clinical Affairs and COO, PhD (1)